Freeze-and-Drug combo tested for rare, aggressive tumors
NCT ID NCT05949099
Summary
This study is testing a two-part treatment to control desmoid tumors, which are non-cancerous but can be painful and damaging. Adults with a progressing or symptomatic tumor will take an oral drug (nirogacestat) for about 3 months, then undergo a single freezing procedure (cryoablation) to destroy most of the tumor, followed by more drug therapy for up to 2 years. The main goal is to see if this combination stops tumor growth or shrinks it for at least a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94395, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.